ESR1 and urinary bladder carcinoma: Moreover, other molecular modifications associated with T24 TCC line and/or bladder cancer tissues have been found and they can be correlated with ATRA resistance as RARβ silencing by aberrant methylation [21], and the absence of the estrogen receptor, or rather estrogen receptor negative (ER-) [22,23].